Cidara Therapeutics Inc (CDTX)
13.43
+0.40
(+3.07%)
USD |
NASDAQ |
Nov 05, 16:00
13.43
0.00 (0.00%)
After-Hours: 18:05
Cidara Therapeutics Profit Margin (Quarterly): -30.20K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -30.20K% |
| March 31, 2024 | -122.0% |
| December 31, 2023 | -31.91% |
| September 30, 2023 | -64.26% |
| June 30, 2023 | -267.7% |
| March 31, 2023 | 11.54% |
| December 31, 2022 | -165.4% |
| September 30, 2022 | 36.76% |
| June 30, 2022 | -211.1% |
| March 31, 2022 | -257.2% |
| Date | Value |
|---|---|
| December 31, 2021 | -232.6% |
| September 30, 2021 | -255.6% |
| June 30, 2021 | 32.59% |
| March 31, 2021 | -759.6% |
| December 31, 2020 | -580.2% |
| September 30, 2020 | -729.8% |
| June 30, 2020 | -539.7% |
| March 31, 2020 | -574.7% |
| December 31, 2019 | -772.6% |
| September 30, 2019 | 15.91% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-30.20K%
Minimum
Jun 2024
36.76%
Maximum
Sep 2022
-1.88K%
Average
-255.6%
Median
Sep 2021
Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 14.22% |
| Arbutus Biopharma Corp | -1.15K% |
| GlycoMimetics Inc | -- |
| FibroGen Inc | -30.69% |
| Cue Biopharma Inc | -382.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -449.1% |
| Return on Assets | -135.8% |
| Return on Invested Capital | -449.1% |
| Operating Margin (Quarterly) | -3.68K% |
| Return on Net Operating Assets | -757.8% |